Alaska Medicaid and GLP-1s
There is no Alaska criteria document for these drugs. There is a list, and on it three rows: Wegovy added in May 2024, Zepbound in January 2025, Wegovy tablets in December 2025, each marked with the same class code — verification of a covered, labeled indication required. What counts as covered is not written on the page. Mounjaro, by contrast, sits in a harsher class that demands two prior failures.
What changed, and what the document says
One class code, three drugs, no criteria
Conditions applyThe entire published requirement for these products is this line. It asks for a labeled indication and says nothing about weight, BMI or a sleep study.
“Class 0: verification of covered, labeled indication required”
Alaska Department of Health — Last Updated 07/28/2026
The list is interim, and says so in its title
ContextAlaska calls its own document interim, which is a fair description of a policy expressed as a spreadsheet row.
“Alaska Medicaid Interim Prior Authorization List”
Alaska Department of Health — Last Updated 07/28/2026
Mounjaro is treated more harshly than Zepbound
ContextThe diabetes product carries a step-therapy class while the obesity-labeled one does not — the opposite of the pattern in most states here.
“Class 2: at least 2 previously failed therapies required”
Alaska Department of Health — Last Updated 07/28/2026
Read on a list updated in July
ContextThe date matters because a row can be added or removed without any bulletin anywhere.
“Last Updated 07/28/2026”
Alaska Department of Health — Last Updated 07/28/2026
The drug list does not mention them at all
Not coveredAll 5,825 non-blank lines of the June 2026 drug list were read. None of the three weight-management products appears, and neither does the word obesity or the word weight — while every diabetes GLP-1 is there, which is what shows the scan works.
“Effective Date 06/01/2026”
Alaska Department of Health — Effective Date 06/01/2026
What the state didn't publish
Alaska's Medicaid drug list names no weight-management GLP-1, and does not contain the word obesity or the word weight anywhere.
We looked at 5825 documents to say that — All 5,825 non-blank lines of the Preferred Drug List effective June 1, 2026, read as text end to end.
The identical scan, same run, same 5,825 lines: insulin 197, metformin 129, Mounjaro 6, Trulicity 6, Ozempic 5, Rybelsus 4, Victoza 1. The ruler finds GLP-1 brand names in this document, which is the same kind of token Wegovy and Zepbound are, and against those same lines Wegovy, Zepbound, Saxenda, obesity and weight each returned zero.
Checked September 2026 against Alaska Medicaid Preferred Drug List (PDL), Alaska Department of Health.
Which of these companies serve Alaska?
Of the 242 companies we grade, 25 publish a list of the states they are licensed in. We checked 214 more and found no such list on any page we read; 3 we have not checked either way.
14 of those lists name Alaska: Gala Health, Care Bare Rx, Vita Bella, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Trimi, Enhance MD, HumeCare+, Mojoon and Peak Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Sources
Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.
- Alaska Medicaid Interim Prior Authorization List — Alaska Department of Health. Printed top right of page 1: Last Updated 07/28/2026.
- Alaska Medicaid Preferred Drug List (PDL) — Alaska Department of Health. Printed in the header of every page. ⛔ Individual rows carry their own separate 'status change effective date' column — one document, several ages: Effective Date 06/01/2026.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
None of the above changes what a telehealth seller charges you. None of the 3 rows below carries both a medication price and a monthly fee we could capture, so no figure here is a sum. Each cell says what its number covers and what we could not confirm, and every number was read on the seller's own page.
1 of these 3 pays us a commission if you start there: Eden. NovoCare Pharmacy and Hello Alpha pay us nothing. A commission never changes a grade.
| Grade | Provider | What a month actually costs | The one thing that matters here | Go to the provider |
|---|---|---|---|---|
| BMinor gap | NovoCare Pharmacy | $149a month, medication onlybrand Wegovy tablets 1.5 mgMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.Self-pay. One month is one bottle of 30 tablets.The lowest of the 9 medication prices we captured here | Sells Wegovy tablets at $149, $199 and $299 by strength — the exact product Alaska added to its list in December 2025 without publishing a single criterion for it. | See its prices at NovoCare Pharmacy (opens in a new tab)Pays us nothing |
| CCaveat | Eden | $99a month, medication onlycompounded semaglutide, all-inclusive monthlyMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.The partner page's price, and the total its checkout showed. Eden's main site prices the same drug as medication only, plus a separate membership.The lowest of the 2 medication prices we captured here | All-inclusive monthly pricing at $99 for semaglutide and $129 for tirzepatide, which is a firmer number than a class code that does not say what it covers. | See its prices at Eden (opens in a new tab)Pays us a commission |
| CCaveat | Hello Alpha | No month-to-month medication price we could capture, so there is no monthly total to show.What they do bill every month: $79 a month for Plus+ membership, $29 a month for Basic membership.The review says what else we found. | Memberships at $29 and $79 with the medication billed on top, worth knowing in a state where the plan's own requirement is not written down. | See its prices at Hello Alpha (opens in a new tab)Pays us nothing |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.